Analyst Consensus ?
ConsensusBuy25 ratings
Bullish1768.0%
Neutral728.0%
Bearish14.0%
FN2 Earnings Intelligence
Philip Morris International Inc. (PM) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 26, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| UBS | Neutral | Neutral | Maintain | Oct 22, 2026 |
| Needham | Buy | Buy | Maintain | Oct 22, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 30, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 29, 2026 |
| Stifel | Buy | Buy | Maintain | Jul 23, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jan 20, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Nov 26, 2025 |
| B of A Securities | Buy | Buy | Maintain | Jun 4, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 1, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Sep 26, 2024 |
| Argus Research | Hold | Buy | Downgrade | Mar 5, 2024 |
| Societe Generale | Hold | Sell | Upgrade | Feb 13, 2024 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Feb 13, 2020 |
| Piper Sandler | Overweight | Overweight | Maintain | Jan 7, 2020 |
| Wells Fargo | Outperform | Outperform | Maintain | Oct 18, 2019 |
| Bank of America | Buy | Neutral | Upgrade | Oct 1, 2019 |
| Credit Suisse | Underperform | Neutral | Downgrade | Dec 18, 2018 |
| Argus | Buy | Hold | Upgrade | Jul 25, 2018 |
| Stifel Nicolaus | Buy | Buy | Maintain | Jul 20, 2018 |
| SBG Securities | Hold | Sell | Upgrade | Aug 11, 2017 |
| CLSA | Buy | Outperform | Maintain | Nov 14, 2016 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Mar 8, 2016 |
| Nomura | Neutral | Reduce | Upgrade | Nov 30, 2015 |
| FirstEnergy Capital | Market Perform | Outperform | Downgrade | Feb 21, 2014 |
Upside is calculated against the persisted current price $201.2. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| UBS | Analyst unavailable | $201 | $201.26 | -0.1% | Oct 22, 2026 |
| UBS | Faham Baig | $192 | $190.23 | -4.6% | Sep 23, 2026 |
| Barclays | Pallav Mittal | $225 | $200.17 | +11.8% | Jul 29, 2026 |
| BTIG | Analyst unavailable | $221 | $191.12 | +9.8% | Jul 24, 2026 |
| Stifel Nicolaus | Analyst unavailable | $205 | $194.3 | +1.9% | Jul 23, 2026 |
| Needham | Gerald Pascarelli | $215 | $194.3 | +6.9% | Jul 23, 2026 |
| Morgan Stanley | Analyst unavailable | $215 | $194.3 | +6.9% | Jul 23, 2026 |
| BTIG | Analyst unavailable | $216 | $188.04 | +7.4% | Jul 21, 2026 |
| UBS | Analyst unavailable | $182 | $180.7 | -9.5% | Jul 2, 2026 |
| Morgan Stanley | Analyst unavailable | $200 | $173.66 | -0.6% | Jun 3, 2026 |
| UBS | Analyst unavailable | $168 | $157.11 | -16.5% | Apr 17, 2026 |
| Morgan Stanley | Eric Serotta | $190 | $156.58 | -5.6% | Apr 17, 2026 |
| Stifel Nicolaus | Matthew Smith | $195 | $158.68 | -3.1% | Apr 10, 2026 |
| Barclays | Analyst unavailable | $205 | $183.4 | +1.9% | Feb 23, 2026 |
| UBS | Analyst unavailable | $181.5 | $180.24 | -9.8% | Feb 9, 2026 |
| Morgan Stanley | Eric Serotta | $205 | $182.81 | +1.9% | Feb 9, 2026 |
| Stifel Nicolaus | Analyst unavailable | $200 | $182.81 | -0.6% | Feb 9, 2026 |
| Jefferies | Edward Mundy | $180 | $173.62 | -10.5% | Jan 20, 2026 |
| Morgan Stanley | Eric Serotta | $175 | $152 | -13.0% | Oct 22, 2025 |
| Stifel Nicolaus | Analyst unavailable | $180 | $152 | -10.5% | Oct 22, 2025 |
| Stifel Nicolaus | Matthew Smith | $186 | $150.17 | -7.6% | Oct 21, 2025 |
| UBS | Faham Baig | $181 | $180.37 | -10.0% | Jul 14, 2025 |
| Barclays | Gaurav Jain | $155 | $131.57 | -23.0% | Oct 30, 2024 |
| Deutsche Bank | Damian McNeela | $142 | $131.41 | -29.4% | Oct 22, 2024 |
| Citigroup | Simon Hales | $132 | $118.91 | -34.4% | Oct 8, 2024 |
| Deutsche Bank | Damian McNeela | $135 | $121.4 | -32.9% | Oct 1, 2024 |
| Barclays | Gaurav Jain | $145 | $125.81 | -27.9% | Sep 9, 2024 |
| Bank of America Securities | Lisa Lewandowski | $139 | $125.71 | -30.9% | Sep 4, 2024 |
| Stifel Nicolaus | Matthew Smith | $138 | $125.71 | -31.4% | Sep 4, 2024 |
| Stifel Nicolaus | Matthew Smith | $115 | $110.24 | -42.8% | Jul 24, 2024 |
| Stifel Nicolaus | Matthew Smith | $120 | $109.56 | -40.4% | Jul 24, 2024 |
| Goldman Sachs | Bonnie Herzog | $118 | $94.06 | -41.4% | Apr 23, 2024 |
| Morgan Stanley | Pamela Kaufman | $113 | $90.27 | -43.8% | Oct 3, 2023 |
| Argus Research | David Coleman | $110 | $98.77 | -45.3% | Jul 20, 2023 |
| Morgan Stanley | Pamela Kaufman | $118 | $97.36 | -41.4% | Jun 29, 2023 |
| Jefferies | Stephanie Wissink | $150 | $95.08 | -25.4% | May 4, 2023 |
| Stifel Nicolaus | Matthew Smith | $114 | $98.16 | -43.3% | Apr 24, 2023 |
| Jefferies | Analyst unavailable | $99 | $90.6 | -50.8% | Jul 19, 2022 |
| Deutsche Bank | Brian Mullan | $109 | $98.16 | -45.8% | May 6, 2022 |
| Bank of America Securities | Lisa Lewandowski | $117 | $102.69 | -41.8% | Apr 24, 2022 |
| Morgan Stanley | Pamela Kaufman | $112 | $103.53 | -44.3% | Apr 22, 2022 |
| Stifel Nicolaus | Christopher Growe | $105 | $93.94 | -47.8% | Mar 30, 2022 |
| UBS | Nik Oliver | $110 | $111.61 | -45.3% | Feb 21, 2022 |
| Bernstein | Callum Elliott | $107 | $91.94 | -46.8% | Jun 1, 2021 |
Track every rating change on PM the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.